Knut Olaf Haustein

Summary

Country: Germany

Publications

  1. ncbi request reprint [Nicotine substitution per inhaler. The "cigarette" against addiction]
    K O Haustein
    Instituts für Nikotinforschung und Raucherentwöhnung, Erfurt
    MMW Fortschr Med 144:35-6. 2002
  2. ncbi request reprint Smoking and poverty
    Knut Olaf Haustein
    Fritz Lickint Institute for Nicotine Research and Smoking Cessation, Erfurt, Germany
    Eur J Cardiovasc Prev Rehabil 13:312-8. 2006
  3. ncbi request reprint [Health consequences of passive smoking]
    K O Haustein
    Institut für Nikotinforschung und Raucherentwöhnung, Erfurt, Deutschland
    Wien Med Wochenschr 150:233-44. 2000
  4. ncbi request reprint [Smoking and low socio-economic status]
    K O Haustein
    Fritz Lickint Institut für Nikotinforschung und Raucherentwöhnung, Erfurt
    Gesundheitswesen 67:630-7. 2005
  5. ncbi request reprint Changes in hemorheological and biochemical parameters following short-term and long-term smoking cessation induced by nicotine replacement therapy (NRT)
    K O Haustein
    Fritz Lickint Institute for Nicotine Research and Smoking Cessation, Erfurt, Germany
    Int J Clin Pharmacol Ther 42:83-92. 2004
  6. ncbi request reprint [Weight increase after smoking cessation--fate or lack of self-discipline?]
    Knut Olaf Haustein
    Fritz Lickint Institut für Nikotinforschung und Raucherentwöhnung, Erfurt
    Med Monatsschr Pharm 27:168-9. 2004
  7. ncbi request reprint What can we do in secondary prevention of cigarette smoking?
    Knut Olaf Haustein
    Fritz Lickint Institute for Nicotine Research and Smoing Cessation, Erfurt, Germany
    Eur J Cardiovasc Prev Rehabil 10:476-85. 2003
  8. ncbi request reprint [Smoking and body weight--a main topic]
    K O Haustein
    Fritz Lickint Institut für Nikotinforschung und Raucherentwöhnung, Erfurt
    Dtsch Med Wochenschr 128:2085-90. 2003
  9. ncbi request reprint Comparison of the effects of combined nicotine replacement therapy vs. cigarette smoking in males
    Knut Olaf Haustein
    Institute of Nicotine Research and Smoking, Cessation Erfurt, Germany
    Nicotine Tob Res 5:195-203. 2003
  10. ncbi request reprint Bupropion: pharmacological and clinical profile in smoking cessation
    K O Haustein
    Institute for Nicotine Research and Smoking Cessation, Erfurt, Germany
    Int J Clin Pharmacol Ther 41:56-66. 2003

Detail Information

Publications13

  1. ncbi request reprint [Nicotine substitution per inhaler. The "cigarette" against addiction]
    K O Haustein
    Instituts für Nikotinforschung und Raucherentwöhnung, Erfurt
    MMW Fortschr Med 144:35-6. 2002
  2. ncbi request reprint Smoking and poverty
    Knut Olaf Haustein
    Fritz Lickint Institute for Nicotine Research and Smoking Cessation, Erfurt, Germany
    Eur J Cardiovasc Prev Rehabil 13:312-8. 2006
    ..Within the next few years, effective prevention programs against smoking must be developed, particularly for the lower socio-economic populations, in order to stop the cost of healthcare systems spiraling over the coming decades...
  3. ncbi request reprint [Health consequences of passive smoking]
    K O Haustein
    Institut für Nikotinforschung und Raucherentwöhnung, Erfurt, Deutschland
    Wien Med Wochenschr 150:233-44. 2000
    ..More than up to date, the non-smoker must be informed about the risks and damages of ETS...
  4. ncbi request reprint [Smoking and low socio-economic status]
    K O Haustein
    Fritz Lickint Institut für Nikotinforschung und Raucherentwöhnung, Erfurt
    Gesundheitswesen 67:630-7. 2005
    ..Within the next few years, effective prevention programmes against smoking must be developed, particularly for the lower socio-economic populations, to prevent the cost of health care systems spiralling during the next few decades...
  5. ncbi request reprint Changes in hemorheological and biochemical parameters following short-term and long-term smoking cessation induced by nicotine replacement therapy (NRT)
    K O Haustein
    Fritz Lickint Institute for Nicotine Research and Smoking Cessation, Erfurt, Germany
    Int J Clin Pharmacol Ther 42:83-92. 2004
    ..We investigated the effect of stopping smoking by using nicotine replacement therapy (NRT) on hemorheology parameters, on the cotinine and thiocyanate plasma concentrations and the exhaled carbon monoxide (CO)...
  6. ncbi request reprint [Weight increase after smoking cessation--fate or lack of self-discipline?]
    Knut Olaf Haustein
    Fritz Lickint Institut für Nikotinforschung und Raucherentwöhnung, Erfurt
    Med Monatsschr Pharm 27:168-9. 2004
  7. ncbi request reprint What can we do in secondary prevention of cigarette smoking?
    Knut Olaf Haustein
    Fritz Lickint Institute for Nicotine Research and Smoing Cessation, Erfurt, Germany
    Eur J Cardiovasc Prev Rehabil 10:476-85. 2003
    ..are briefly mentioned. Overall, we need greater efforts in practising primary and secondary prevention among current and future physicians to solve the health problems associated with tobacco use in many nations...
  8. ncbi request reprint [Smoking and body weight--a main topic]
    K O Haustein
    Fritz Lickint Institut für Nikotinforschung und Raucherentwöhnung, Erfurt
    Dtsch Med Wochenschr 128:2085-90. 2003
  9. ncbi request reprint Comparison of the effects of combined nicotine replacement therapy vs. cigarette smoking in males
    Knut Olaf Haustein
    Institute of Nicotine Research and Smoking, Cessation Erfurt, Germany
    Nicotine Tob Res 5:195-203. 2003
    ..The safety of combination NRT was confirmed by the absence of overdose-related adverse events...
  10. ncbi request reprint Bupropion: pharmacological and clinical profile in smoking cessation
    K O Haustein
    Institute for Nicotine Research and Smoking Cessation, Erfurt, Germany
    Int J Clin Pharmacol Ther 41:56-66. 2003
    ..As the risk-benefit ratio of BP is smaller than that of nicotine replacement, BP should be considered as a second-line treatment in smoking cessation...
  11. ncbi request reprint A review of the pharmacological and psychopharmacological aspects of smoking and smoking cessation in psychiatric patients
    K O Haustein
    Institute for Nicotine Research and Smoking Cessation, Erfurt, Germany
    Int J Clin Pharmacol Ther 40:404-18. 2002
    ..Because patients with mental diseases are particularly vulnerable to the marketing strategies of the tobacco industry, this chronically ill section of the population requires special protection by the law-makers...
  12. ncbi request reprint Effects of cigarette smoking or nicotine replacement on cardiovascular risk factors and parameters of haemorheology
    K O Haustein
    Institute of Nicotine Research and Smoking Cessation, Erfurt, Germany
    J Intern Med 252:130-9. 2002
    ..4 ppm at baseline to 4.2 ppm; P < 0.0001). Conclusions. Smoking cessation improved CV parameters, and use of nicotine medications did not negate these improvements...
  13. ncbi request reprint [Health consequences of passive smoking]
    K O Haustein
    Institut für Nikotinforschung und Raucherentwöhnung, Erfurt
    Z Arztl Fortbild Qualitatssich 95:377-86. 2001
    ..Non-smokers must be informed about the risks and dangers of ETS more than it is the case up to now...